SOD1 and amyotrophic lateral sclerosis: Furthermore, a cysteine residue of SOD1 is oxidatively modified in CSF from sporadic ALS patients, indicating an increased fraction of sulfenylated (-SOH) [36] and sulfonylated (-SO3H) [16] SOD1 in the extracellular environment of ALS patients.